Kite Earns Patent for Method to Increase Efficacy of CAR-T
Company Snags Rights for Use of Optimal Preconditioning Regimen
The Challenge of Immunotherapy: Staying on Target
Immunotherapies Can Produce Side Effects That Mimic Autoimmune Diseases
Seeking New Users for iSeq
The Changing Sequencing Landscape
Vaccine Industry Retools Itself for Speed
Vaccine Manufacturing Moves toward Mass Customization
For full access to this article login to GEN Select now.
Taming Difficult to Express Proteins
- In small molecule drug development, it is often said that the low-hanging fruit has already been harvested. Most structures that are chemically accessible, manufacturable, and druggable have already been considered. Somewhat analogously, the leading edge in biologics development are proteins that for one reason or other present development ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.